Concepedia

Kunihiko Tatsumi

KT

Statistics

Publications

6

Citations

708

H-Index

6

Active since

1987

Affiliations

Otsuka (Japan)(Current)

Otsuka Pharmaceutical (Spain)

Kunihiko Tatsumi is an author at Otsuka (Japan) specializing in pharmacology, enzyme inhibition, and biochemistry.

Publications per year

1987–1999

6

Publications

6

A novel brain-specific p53-target gene, BAI1, containing thrombospondin type 1 repeats inhibits experimental angiogenesis

Hiroyuki Nishimori, Takayuki Shiratsuchi, Tsutomu Urano et al. · Oncogene · 1997 · 292 citations

, , +7

Inhibitory effects of pyrimidine, barbituric acid and pyridine derivatives on 5-fluorouracil degradation in rat liver extracts.

Kunihiko Tatsumi, Masakazu Fukushima, Tetsuhiko Shirasaka et al. · PubMed · 1987 · 261 citations

, , +10

2‐Isopropylidenehydrazono‐4‐oxo‐thiazolidin‐5‐ylacetanilide (OPB‐9195) treatment inhibits the development of intimal thickening after balloon injury of rat carotid artery: role of glycoxidation and lipoxidation reactions in vascular tissue damage

Toshio Miyata, Shintaro Ishikawa, Koichi Asahi et al. · FEBS Letters · 1999 · 82 citations · Full text

, , +15

A Novel Xanthine Dehydrogenase Inhibitor (BOF-4272)

Seiji Sato, Kunihiko Tatsumi, Takeshi Nishino · Advances in experimental medicine and biology · 1991 · 35 citations

, , +6

3-Cyano-2, 6-Dihydroxypyridine (CNDP), a New Potent Inhibitor of Dihydrouracil Dehydrogenase

Kunihiko Tatsumi, Takeshi Yamauchi, Kunihiko Kiyono et al. · The Journal of Biochemistry · 1993 · 23 citations

, , +14

1–5 of 6